A High-Dimensional Window into the Micro-Environment of Triple Negative Breast Cancer

Autor Nederlof, Iris, Horlings, Hugo M., Curtis, Christina, Kok, Marleen
Vydáno v Cancers (Basel) (2021)

Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck

Autor Persson, Marta, Andrén, Ywonne, Mark, Joachim, Horlings, Hugo M., Persson, Fredrik, Stenman, Göran
Vydáno 2009

Low grade serous carcinoma of the peritoneum in a BRCA1 carrier previously diagnosed with a “low-grade serous tubal intra-epithelial carcinoma” (STIC) on risk reducing surgery

Autor Chay, Wen Yee, Horlings, Hugo M., Tinker, Anna V., Gelmon, Karen A., Gilks, C.Blake
Vydáno v Gynecol Oncol Rep (2015)

Integration of Clinical and Gene Expression Data Has a Synergetic Effect on Predicting Breast Cancer Outcome

Autor van Vliet, Martin H., Horlings, Hugo M., van de Vijver, Marc J., Reinders, Marcel J. T., Wessels, Lodewyk F. A.
Vydáno 2012

Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability

Autor van Vliet, Martin H, Reyal, Fabien, Horlings, Hugo M, van de Vijver, Marc J, Reinders, Marcel JT, Wessels, Lodewyk FA
Vydáno 2008

Retrospective analysis of metastatic behaviour of breast cancer subtypes

Autor Savci-Heijink, C. Dilara, Halfwerk, Hans, Hooijer, Gerrit K. J., Horlings, Hugo M., Wesseling, Jelle, van de Vijver, Marc J.
Vydáno v Breast Cancer Res Treat (2015)

Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer

Autor Lin, Cong, Majoor, Christof J., Roelofs, Joris J. T. H., de Kruif, Martijn D., Horlings, Hugo M., Borensztajn, Keren, Spek, C. Arnold
Vydáno v BMC Cancer (2017)

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations

Autor van de Vijver Marc J, Børresen-Dale Anne-Lise, Langerød Anita, Velds Arno, Horlings Hugo M, Holstege Henne, Nederlof Petra M, Jonkers Jos
Vydáno 2010-11-01

SIRAC: Supervised Identification of Regions of Aberration in aCGH datasets

Autor Nederlof Petra M, van Beers Eric H, van de Vijver Marc J, Horlings Hugo M, Lai Carmen, Wessels Lodewyk FA, Reinders Marcel JT
Vydáno 2007-10-01

SIRAC: Supervised Identification of Regions of Aberration in aCGH datasets

Autor Lai, Carmen, Horlings, Hugo M, van de Vijver, Marc J, van Beers, Eric H, Nederlof, Petra M, Wessels, Lodewyk FA, Reinders, Marcel JT
Vydáno 2007

BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations

Autor Holstege, Henne, Horlings, Hugo M, Velds, Arno, Langerød, Anita, Børresen-Dale, Anne-Lise, van de Vijver, Marc J, Nederlof, Petra M, Jonkers, Jos
Vydáno 2010

Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets

Autor Farazi, Thalia A, ten Hoeve, Jelle J, Brown, Miguel, Mihailovic, Aleksandra, Horlings, Hugo M, van de Vijver, Marc J, Tuschl, Thomas, Wessels, Lodewyk FA
Vydáno 2014

EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer

Autor Pietersen, Alexandra M, Horlings, Hugo M, Hauptmann, Michael, Langerød, Anita, Ajouaou, Abderrahim, Cornelissen-Steijger, Paulien, Wessels, Lodewijk F, Jonkers, Jos, Vijver, Marc J van de, van Lohuizen, Maarten
Vydáno 2008

Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity

Autor Léveillé, Nicolas, Elkon, Ran, Davalos, Veronica, Manoharan, Vijayalaxmi, Hollingworth, Dave, Vrielink, Joachim Oude, le Sage, Carlos, Melo, Carlos A., Horlings, Hugo M., Wesseling, Jelle, Ule, Jernej, Esteller, Manel, Ramos, Andres, Agami, Reuven
Vydáno 2011

Abrogation of BRAF(V600E)-induced senescence by PI3K pathway activation contributes to melanomagenesis

Autor Vredeveld, Liesbeth C.W., Possik, Patricia A., Smit, Marjon A., Meissl, Katrin, Michaloglou, Chrysiis, Horlings, Hugo M., Ajouaou, Abderrahim, Kortman, Pim C., Dankort, David, McMahon, Martin, Mooi, Wolter J., Peeper, Daniel S.
Vydáno 2012

Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation

Autor Groenendijk, Floris H, Mellema, Wouter W, van der Burg, Eline, Schut, Eva, Hauptmann, Michael, Horlings, Hugo M, Willems, Stefan M, van den Heuvel, Michel M, Jonkers, Jos, Smit, Egbert F, Bernards, René
Vydáno v Int J Cancer (2015)

Identification of breast cancer cell subtypes sensitive to ATG4B inhibition

Autor Bortnik, Svetlana, Choutka, Courtney, Horlings, Hugo M., Leung, Samuel, Baker, Jennifer H., Lebovitz, Chandra, Dragowska, Wieslawa H., Go, Nancy E., Bally, Marcel B., Minchinton, Andrew I., Gelmon, Karen A., Gorski, Sharon M.
Vydáno v Oncotarget (2016)

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

Autor Turner, Nicholas, Lambros, Maryou B, Horlings, Hugo M., Pearson, Alex, Sharpe, Rachel, Natrajan, Rachael, Geyer, Felipe C, van Kouwenhove, Marieke, Kreike, Bas, Mackay, Alan, Ashworth, Alan, van de Vijver, Marc J, Reis-Filho, Jorge S
Vydáno 2010

Functional Profiling of FSH and Estradiol in Ovarian Granulosa Cell Tumors

Autor Haltia, Ulla-Maija, Pihlajoki, Marjut, Andersson, Noora, Mäkinen, Lotta, Tapper, Johanna, Cervera, Alejandra, Horlings, Hugo M, Turpeinen, Ursula, Anttonen, Mikko, Bützow, Ralf, Unkila-Kallio, Leila, Carpén, Olli, Wilson, David B, Heikinheimo, Markku, Färkkilä, Anniina
Vydáno v J Endocr Soc (2020)

Systematic analysis of somatic mutations impacting gene expression in 12 tumour types

Autor Ding, Jiarui, McConechy, Melissa K., Horlings, Hugo M., Ha, Gavin, Chun Chan, Fong, Funnell, Tyler, Mullaly, Sarah C., Reimand, Jüri, Bashashati, Ali, Bader, Gary D., Huntsman, David, Aparicio, Samuel, Condon, Anne, Shah, Sohrab P.
Vydáno v Nat Commun (2015)